All News

The DEA’s decision allows some health care providers to have more leeway in prescribing certain controlled substances.

Navigating the Transition to Year-Round Immunization

Never have there been so many opportunities for non–dispensing pharmacist roles. At the same time, there has never been such a need to save the dispensing environment.

Pfizer Inc’s bivalent respiratory syncytial virus (RSV) vaccine Abrysvo is indicated to prevent lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.

Former and current smokers showed higher mortality from early-stage non-small cell lung cancer than never smokers.

Pediatric drug development, which has a complex background and history, has fundamental catches based around how children are defined in the context of clinical studies.

Products include an antidepressant and treatment for hypertension.

As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.

Radio frequency identification-enabled automation for inventory management has only achieved its massive adoption in the retail space over the past 2 decades.

The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate.

Repotrectinib is a promising next-generation tyrosine kinase inhibitor under investigation for the treatment of ROS1-positive locally advanced or metastatic non-small cell lung cancer.

In the initial cohort, 63% of patients with advanced melanoma achieved an objective response rate, including 6 who had a complete response and 19 who had a partial response to the combination of fianlimab and cemiplimab.

Products include a new FDA-approved treatment for dermatitis in younger individuals and a continuous glucose monitoring sensor system.

Adagrasib is a RAS GTPase family inhibitor with objective response rate in patients with certain types of locally advanced or metastatic non–small cell lung cancer (NSCLC).

Study findings suggest surveillance and prevention programs are needed for this common and deadly complication of hospitalization.

Study shows 18.4% of patients with relapsed or refractory chronic lymphocytic leukemia treated with lisocabtagene maraleucel achieved a complete response (CR), with median duration of CR not reached at median follow-up of 21.1 months.

A professional with a newly-minted pharmacy doctorate degree today has many options for a rewarding career.

Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.

Untreated hearing loss can affect communication, loneliness, and lead to severe illness, such as dementia.

Sue Ojageer discusses the new coloring book she created to explore different pharmaceutical career paths.

Cases discuss triglyceride levels, supplement use, and more.

Cases address gastrointestinal issues and alcohol abuse.

Multiple myeloma treatment selection is critical due to the potential for developing treatment resistance over time to the currently prescribed drugs.

In Greece, the stark increase in Clostridioides difficile (C. diff) incidence cannot be explained by a rise of antimicrobial use during the pandemic.

With no treatments currently FDA approved, patients arrive at the hospital with no options for treatment beside waiting for the intoxication to pass.

Bictegravir/emtricitabine/ tenofovir alafenamide tablets (B/F/TAF) provides long-term virologic suppression for nearly 100% of patients.

This is the first clinical evidence to show that stimulating the programmed cell death protein 1 (PD1) inhibitory pathway is beneficial for rheumatologic disease.

Program Chair Ryan Haumschild, PharmD, MS, MBA, discussed what attendees can look forward to at the inaugural Oncology Pharmacists Connect meeting.

Patients with depression require long-term treatment and supportive care, either with medications or non-pharmaceutical options.